Pharmaceuticals Market Research Reports

Global Adiponectin Testing Market By Product Type (Assay Kits, and Reagents & Consumables), By Species Type (Human, Rat, Mouse, and Others), By End-user (Research & Academic Institutes, Diagnostic Labs, and Hospitals), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview Global Adiponectin Testing Market size is expected to be worth around US$ 108.9 Billion by 2034 from US$ 51.4 Billion in 2024, growing at a CAGR of 7.8% during the fo...
- ★★★★★
  
  ★★★★★
  
  (142)
- Oct 2025
- Pages: 269
- US $3,999 Onwards
- Formats:
Global Monoclonal Antibodies Market By Product Type (Human, Murine, and Chimeric), By Technology (In Vitro, and In Vivo), By Application (Oncology, Neurological Diseases, Infectious Diseases, Autoimmune Diseases, and Others), By End-user (Hospitals, Specialty Centers, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview Global Monoclonal Antibodies Market size is expected to be worth around US$ 894.0 Billion by 2034 from US$ 265.7 Billion in 2024, growing at a CAGR of 12.9% during th...
- ★★★★★
  
  ★★★★★
  
  (42)
- Oct 2025
- Pages: 286
- US $3,999 Onwards
- Formats:
Global Creatine Kinase Reagent Market By Product Type (Reagents, Instruments, and Kits), By Test (Enzymatic Tests, Point of Care Tests, ELISA-based Tests, Colorimetric Assay Based Tests, and Others), By Application (Research, and Diagnosis), By End-user (Hospitals & Clinics, Diagnostic Laboratories, Academic Research Institutes, and Other), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview Global Creatine Kinase Reagent Market size is expected to be worth around US$ 1039.7 Million by 2034 from US$ 376.2 Million in 2024, growing at a CAGR of 10.7% during...
- ★★★★★
  
  ★★★★★
  
  (142)
- Oct 2025
- Pages: 273
- US $3,999 Onwards
- Formats:
Global Migraine Market By Therapeutic Use (Acute, Preventive) By Therapeutic Class (CGRP monoclonal antibodies, CGRP small molecule antagonists, Acetylcholine inhibitors/ neurotoxins, Triptans, Ditans, Ergot alkaloids, NSAIDs, Others) By Route of Administration (Oral, Injectable, Others) By Age Group (Pediatric, Adult, Geriatric) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Report Overview Global Migraine Market size is expected to be worth around US$ 18.86 Billion by 2034 from US$ 6.95 Billion in 2024, growing at a CAGR of 10.5% during the forecast per...
- ★★★★★
  
  ★★★★★
  
  (142)
- Oct 2025
- Pages: 257
- US $3,999 Onwards
- Formats:
Global Doxycycline Market Analysis By Formulation Type (Oral (Tablets, Capsules, Oral Suspension), Injectable (Intravenous, Intramuscular), Topical), By Therapeutic Application (Infectious Diseases (Respiratory Tract Infections, Sexually Transmitted Infections, Intestinal Infections, Urinary Tract Infections, Others), Acne Vulgaris), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Pharmacies) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Doxycycline Market size is expected to be worth around US$ 4.4 Billion by 2034, from US$ 2.4 Billion in 2024, growing at a CAGR of 6.3% during the forecast...
- ★★★★★
  
  ★★★★★
  
  (142)
- Oct 2025
- Pages: 394
- US $3,999 Onwards
- Formats:
Generic Injectable Market By Product Type (Monoclonal Antibodies, Vaccines, Small Molecule Antibiotics, Peptide Hormone, Peptide Antibiotics, Insulin, Immunoglobin, Cytokines, Chemotherapy Agents, and Blood Factors), By Molecular Type (Large Molecule, and Small Molecule), By Application (Oncology, Pain Management, Musculoskeletal Disorders, Infectious Diseases, Hormonal Disorders, Diabetes, CNS Diseases, Cardiovascular Diseases, Blood Disorders, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Drug Stores), By Administration (Intravenous (IV), Subcutaneous (SC), and Intramuscular (IM)), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Generic Injectable Market size is expected to be worth around US$ 419.5 billion by 2034 from US$ 117.2 billion in 2024, growing at a CAGR of 13.6% during the fore...
- ★★★★★
  
  ★★★★★
  
  (142)
- Oct 2025
- Pages: 219
- US $3,999 Onwards
- Formats:

« Previous 1 … 12 13 14 15 16 … 66 Next »